Adaptimmune (ADAP)

Adaptimmune

The time to redefine the treatment of cancer is now.

About Us

Redefining the treatment of solid tumor cancers.

Adaptimmune is committed to treating the most challenging solid tumors using a proprietary cell therapy platform that harnesses a patient's cells to combat their cancer.

Using a personalized approach that has the potential to radically improve the patient experience.

We use cell therapy, a promising yet complex area of science, to engineer a person’s own cells to fight cancer.

A future where a single infusion could reshape cancer care.

We are a fully integrated company on the verge of a new era. With our first BLA submitted to the FDA, we are aiming to commercialize the  first engineered T-cell therapy in solid tumors to help improve cancer treatment.

Allogeneic Construct at the Keystone Symposia Conference on Emerging Cellular Therapies: Cancer and Beyond

Feb 8 - Feb 10, 2020

Presentation details are as follows:
Title: Engineering Off-the-Shelf T Cell Receptor Fusion Construct (TRuC®) T Cells
Poster: 2002 Session Title: Q2: Engineering the Genome
Session Date/Time: February 10, 7:30pm - 10:00pm M.S.T.

Supporting Materials

Engineering Off-the-Shelf T Cell Receptor Fusion Construct (TRuC^TM) T Cells 5.1 MB

Location

Banff, Canada

Adaptimmune (ADAP)

Adaptimmune

The time to redefine the treatment of cancer is now.

About Us

Redefining the treatment of solid tumor cancers.

Adaptimmune is committed to treating the most challenging solid tumors using a proprietary cell therapy platform that harnesses a patient's cells to combat their cancer.

Using a personalized approach that has the potential to radically improve the patient experience.

We use cell therapy, a promising yet complex area of science, to engineer a person’s own cells to fight cancer.

Adaptimmune

Our fight with cancer is personal.

The time to redefine the treatment of cancer is now.

Redefining the treatment of solid tumor cancers.

Using a personalized approach that has the potential to radically improve the patient experience.

A future where a single infusion could reshape cancer care.

Allogeneic Construct at the Keystone Symposia Conference on Emerging Cellular Therapies: Cancer and Beyond

Feb 8 - Feb 10, 2020

Supporting Materials

Location

Adaptimmune

Our fight with cancer is personal.

The time to redefine the treatment of cancer is now.

Redefining the treatment of solid tumor cancers.

Using a personalized approach that has the potential to radically improve the patient experience.

A future where a single infusion could reshape cancer care.